Skip to search formSkip to main contentSkip to account menu

Retacrit

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
  • L. Ratner
  • The New England journal of medicine
  • 2018
  • Corpus ID: 52009950
n engl j med 379;7 nejm.org August 16, 2018 695 logic agents. Although we would encourage evidence-based expansion of clinical… 
2016
Review
2016
Review
2016
Review
2016
ABSTRACT Introduction: There is an essential need for clinicians to understand the development and approval process of… 
2013
2013
2011
2011
  • S. Barlas
  • P & T : a peer-reviewed journal for formulary…
  • 2011
  • Corpus ID: 23097816
President Barack Obama’s budget proposal for fiscal year 2012 reignites a controversy over biosimilar drugs that had been doused… 
Highly Cited
2010
Highly Cited
2010
ABSTRACTPurposeTo compare the quality of therapeutic erythropoietin (EPO) products, including two biosimilars, with respect to… 
Review
2009
Review
2009
2008
2008
  • N. Moran
  • Nature Biotechnology
  • 2008
  • Corpus ID: 205264658
This year will see the first serious engagements in the biogenerics war, as two copycat versions of the world’s biggest-selling… 
2008
2008
Two patients with thalassemia minor and end-stage renal failure on hemodialysis were treated with epoetin zeta (Silapo®, Retacrit…